Generics Industry News Search
 |
|
|
|
|
|
|
August 2014 News Archive |
|
|
| |
|
ANI Pharmaceuticals today announced that it has acquired the US rights for Vancocin 125 mg and 250 mg capsules from Shire, a global biopharmaceutical company...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The country's competition regulator may examine details of patent settlements being negotiated between foreign branded medicine companies and local generic drug makers as these agreements may restrict the access of cheaper drugs to the sick...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Lannett today announced that it has received approval from the FDA of its ANDA for Oxycodone hydrochloride capsules...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Gilead have allowed generic manufacturers in India and China to produce generic versions of its HBV and HIV drug, Tenofovir Alafenamide...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
A federal judge has cried foul over punches thrown by Takeda Pharmaceutical in a patent brawl to decide the fate of a planned generic for its acid reflux drug...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Heritage Pharmaceuticals has signed an exclusive development, supply & distribution agreement with Dexcel for an extended release ANDA drug product...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Generic drugmaker Alvogen said it had agreed to buy South Korea's Dream Pharm for $187 million in cash as part of a push into Asia by the fast-growing U.S.-based company...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mallinckrodt today announced that its subsidiary, Cadence, has entered into settlement and license agreements with Fresenius Kabi resolving pending patent litigation involving Ofirmev...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Pfizer agreed to pay $35 million (20.7937 British million pounds) to 41 U.S. states and Washington, D.C. to settle claims that its Wyeth unit illegally marketed the drug Rapamune...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mallinckrodt today announced that its subsidiary, Cadence Pharmaceuticals, has entered into settlement and license agreements with Fresenius Kabi USA...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Drug firm Zydus Cadila has received the final approval from the US health regulator to market Potassium Citrate ER tablets used in prevention of kidney stones...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Pharmaceutical giant Pfizer is facing a mounting wave of lawsuits by women who allege that the company knew about possible serious side effects of its blockbuster anti-cholesterol drug Lipitor but never properly warned the public...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva Pharmaceutical has confirmed that it has received the first paragraph IV notice for a generic version of its three-times-a-week Copaxone 40 mg/mL treatment...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The Norwegian Medicines Agency approves new potency agent in Norway...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan today announced that it has launched Capecitabine tablets USP, 150 mg and 500 mg, the generic version of Genentech's Xeloda tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
South Korean biopharmaceutical manufacturer Celltrion has announced that it has filed an application for approval with the U.S. FDA for Remsima...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan today announced that it has launched Capecitabine tablets USP, 150 mg and 500 mg, the generic version of Genentech's Xeloda tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Sanofi announced today that it has launched an authorised generic version of Eloxatin (Oxaliplatin injection) through Winthrop...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The Health Ministry has sent a fresh communication to the Department of Industrial Policy & Promotion on why there was an "urgent" need to allow copies of Bristol Myer Squibb's anti-cancer drug Dasatinib to be made in India...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The TGA has agreed, in principle, to participate in a pilot of the Decentralised Procedure (DCP) of the European Union...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The day after Pfizer's patent for Viagra expired in Brazil, Carlos Sanchez flooded pharmacies with his generic erectile dysfunction pills...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Amneal Pharmaceuticals' fast-growing portfolio of approved generic drugs is expanding once again with the launch of four new medications...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Napp Pharmaceuticals has bagged exclusive rights to distribute Celltrion's biosimilar of Johnson and Johnson and Merck and Co's anti-inflammatory blockbuster Remicade in the UK...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Gilead said an arbitration panel rejected Roche's patent infringement claims related to Gilead's hepatitis C drug, Sovaldi...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The U.S. FDA today granted tentative approval for Basaglar (Insulin Glargine injection), which is indicated to improve glycaemic control in adults with type 2 diabetes and in combination with mealtime insulin in adults and paediatric patients with type 1 diabetes...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
A growing number of cases in the pharma sector, where courts forbid Indian drugmakers from launching generic versions of patented drugs...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The government is set to revise the guidelines for evaluating applications seeking intellectual property rights for pharmaceuticals...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Drugmaker Hospira Inc has sued the FDA over its decision to open the doors for competitors to sell generic versions of its patented sedative, Precedex...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Depomed today announced Judge Joel A. Pisano of the U.S. District Court for the District of New Jersey has ruled in favour of Depomed in the company's patent litigation lawsuit against Actavis...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan announced that its business Mylan Institutional has launched Dexmedetomidine hydrochloride injection, 100 mcg (base)/mL, packaged in 200 mcg (base)/2 mL Single-dose Vials, which is therapeutically equivalent to Hospira's Precedex...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
A federal judge has issued a temporary restraining order against the U.S. FDA's decision to allow the sale of generic versions of the Hospira sedative Precedex...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Lannett Company today announced that it has agreed to purchase ANDAs for Estradiol Tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Amerigen announces that its Chinese subsidiary, Suzhou Amerigen, has received CFDA approval and has subsequently launched its generic Mecobalamin 0.5 mg tablets into the China domestic market...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Supernus Pharmaceuticals today announced that on August 20, 2014, the Company received a Paragraph IV Notice Letter from Actavis...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan today announced that it has launched Potassium Chloride extended-release tablets USP, 8 mEq (600 mg) and 10 mEq (750 mg), which is the generic version of Upsher-Smith's Klor-Con...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Actavis today confirmed that it has filed an ANDA with the U.S. FDA seeking approval to market Rotigotine extended-release transdermal film, 1 mg/24 hr, 2mg/24 hr, 3 mg/24hr, 4 mg/24 hr, 6mg/24hr, and 8 mg/24 hr...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Vivus today announced the acquisition of a group of patents from Janssen covering uses of Topiramate...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Fera Pharmaceuticals is pleased to announce that it has been selected by Pragma Pharmaceuticals to launch Amoxicillin extended-release tablets, the authorised generic for Moxatag...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
VIVUS today announced the acquisition of a group of patents from Janssen Pharmaceuticals, covering uses of Topiramate as monotherapy and in combination with other pharmaceutical agents to treat a variety of medical conditions...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Drug firm Strides Arcolab today received approval from the US health regulator for its generic...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
"We remain strongly committed to the U.S. market and we continue to work closely with the FDA to resolve all outstanding issues and to achieve our shared objective of expanding the public's access to quality...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Sandoz, the generic pharmaceutical division of Novartis, today announces the market introduction in Brazil of the first generic version of oncology medicine Bortezomib...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
TWi Pharmaceuticals today announced that it has received final approval from the United States FDA on its ANDA for Megestrol acetate 125mg/ml oral suspension...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan today announced that its ANDA for a three times per week Glatiramer acetate injection 40 mg/ml has been accepted for filing...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Momenta today announced that the FDA has accepted for review the ANDA for a three-times-a-week generic Copaxone...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
United Therapeutics Corporation announced today that the U.S. District
Court for the District of New Jersey has ruled in its favor in the
company's case against Sandoz regarding United Therapeutics' Remodulin
product...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Sandoz today announced the US market introduction of Decitabine for injection, a generic version of Eisai's Dacogen...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Insulin Glargine injections (Basaglar) and inhaled Insulin (Afrezza) are two new diabetes treatment options worth exploring...
|
| |
|
|
Read more >>
|
| |
|
|
|
|
|
Contribute
If you would like to contribute or publish your
company press releases at GenericsWeb, please
email us.
|
Home
